Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 8/2020

18.04.2020 | Original Paper

Left ventricular radial strain impairment precedes hypertrophy in Anderson–Fabry disease

verfasst von: Letizia Spinelli, Giuseppe Giugliano, Massimo Imbriaco, Giovanni Esposito, Carmela Nappi, Eleonora Riccio, Andrea Ponsiglione, Antonio Pisani, Alberto Cuocolo, Bruno Trimarco

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

In Anderson–Fabry disease (AFD), left ventricular (LV) radial function has been scarcely investigated. We hypothesized that LV function may be affected by disease specific mechanisms and sought to comprehensively evaluate LV radial, circumferential and longitudinal function in a large population of AFD patients looking at the influence of LV geometry and fibrosis. We prospectively studied 94 consecutive AFD patients (41.5 ± 14.5 years; 41 men) with preserved LV ejection fraction (EF) utilizing speckle-tracking echocardiography. A subset of patients underwent gadolinium-enhanced cardiac magnetic resonance. Cases were compared to 48 healthy subjects matched for age and sex. LV concentric hypertrophy was found in 33 AFD patients while LV concentric remodeling (relative wall thickness ≥ 0.43) in 16 out 61 patients with normal LV mass. AFD patients had lower radial, longitudinal and circumferential strains than controls, independently by LV geometry pattern. Patients with LV hypertrophy showed reduced global longitudinal strain (p < 0.001) and early diastolic untwisting rate (p = 0.002) as compared to patients with normal geometry. In the whole AFD population, neither radial strain nor circumferential strain correlated with LV mass, while global longitudinal strain and early diastolic untwisting rate did (both p < 0.001). Late gadolinium enhancement was significantly associated with longitudinal strain, twisting rate and early diastolic untwisting rate, with twisting rate being the most powerful independent predictor (β = − 0.461; p = 0.002). Findings demonstrate impairment of LV radial strain in AFD patients with preserved EF, even in a pre-hypertrophic stage. Development of LV hypertrophy and fibrosis make worse mostly longitudinal dysfunction.
Literatur
1.
Zurück zum Zitat Zarate YA, Hopkin RJ (2008) Fabry’s disease. Lancet 372:1427–1435PubMed Zarate YA, Hopkin RJ (2008) Fabry’s disease. Lancet 372:1427–1435PubMed
2.
Zurück zum Zitat Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, Grabowski G, Packman S, Wilcox WR (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338–346PubMed Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, Grabowski G, Packman S, Wilcox WR (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338–346PubMed
3.
Zurück zum Zitat Moon JC, Sachdev B, Elkington AG, McKenna WJ, Mehta A, Pennell DJ, Leed PJ, Elliott PM (2003) Gadolinium enhanced cardiovascular magnetic resonance in anderson-fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 24:2151–2155PubMed Moon JC, Sachdev B, Elkington AG, McKenna WJ, Mehta A, Pennell DJ, Leed PJ, Elliott PM (2003) Gadolinium enhanced cardiovascular magnetic resonance in anderson-fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 24:2151–2155PubMed
4.
Zurück zum Zitat Patel MR, Cecchi F, Cizmarik M, Kantola I, Linhart A, Nicholls K, Strotmann J, Tallaj J, Tran TC, West ML, Beitner-Johnson D, Abiose A (2011) Cardiovascular events in patients with fabry disease natural history data from the fabry registry. J Am Coll Cardiol 57:1093–1099PubMed Patel MR, Cecchi F, Cizmarik M, Kantola I, Linhart A, Nicholls K, Strotmann J, Tallaj J, Tran TC, West ML, Beitner-Johnson D, Abiose A (2011) Cardiovascular events in patients with fabry disease natural history data from the fabry registry. J Am Coll Cardiol 57:1093–1099PubMed
5.
Zurück zum Zitat Arends M, Biegstraaten M, Hughes DA, Mehta A, Elliott PM, Oder D, Watkinson OT, Vaz FM, van Kuilenburg ABP, Wanner C, Hollak CEM (2017) Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: analysis of prognostic factors. PLoS ONE 12:e0182379PubMedPubMedCentral Arends M, Biegstraaten M, Hughes DA, Mehta A, Elliott PM, Oder D, Watkinson OT, Vaz FM, van Kuilenburg ABP, Wanner C, Hollak CEM (2017) Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: analysis of prognostic factors. PLoS ONE 12:e0182379PubMedPubMedCentral
6.
Zurück zum Zitat Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F, Nesser HJ, Khandheria B, Narula J, Sengupta PP (2010) Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr 23:351–368PubMed Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F, Nesser HJ, Khandheria B, Narula J, Sengupta PP (2010) Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr 23:351–368PubMed
7.
Zurück zum Zitat Shanks M, Thompson RB, Paterson ID, Putko B, Khan A, Chan A, Becher H, Oudit GY (2013) Systolic and diastolic function assessment in Fabry disease patients using speckle-tracking imaging and comparison with conventional echocardiographic measurements. J Am Soc Echocardiogr 26:1407–1414PubMed Shanks M, Thompson RB, Paterson ID, Putko B, Khan A, Chan A, Becher H, Oudit GY (2013) Systolic and diastolic function assessment in Fabry disease patients using speckle-tracking imaging and comparison with conventional echocardiographic measurements. J Am Soc Echocardiogr 26:1407–1414PubMed
8.
Zurück zum Zitat Gruner C, Verocai F, Carasso S, Vannan MA, Jamorski M, Clarke JT, Care M, Iwanochko RM, Rakowski H (2012) Systolic myocardial mechanics in patients with Anderson–Fabry disease with and without left ventricular hypertrophy and in comparison to nonobstructive hypertrophic cardiomyopathy. Echocardiography 29:810–817PubMed Gruner C, Verocai F, Carasso S, Vannan MA, Jamorski M, Clarke JT, Care M, Iwanochko RM, Rakowski H (2012) Systolic myocardial mechanics in patients with Anderson–Fabry disease with and without left ventricular hypertrophy and in comparison to nonobstructive hypertrophic cardiomyopathy. Echocardiography 29:810–817PubMed
9.
Zurück zum Zitat Esposito R, Galderisi M, Santoro C, Imbriaco M, Riccio E, Maria Pellegrino A, Sorrentino R, Lembo M, Citro R, Angela Losi M, Spinelli L, Trimarco B, Pisani A (2019) Prominent longitudinal strain reduction of left ventricular basal segments in treatment naïve Anderson–Fabry disease patients. Eur Heart J Cardiovasc Imaging 20:438–445PubMed Esposito R, Galderisi M, Santoro C, Imbriaco M, Riccio E, Maria Pellegrino A, Sorrentino R, Lembo M, Citro R, Angela Losi M, Spinelli L, Trimarco B, Pisani A (2019) Prominent longitudinal strain reduction of left ventricular basal segments in treatment naïve Anderson–Fabry disease patients. Eur Heart J Cardiovasc Imaging 20:438–445PubMed
11.
Zurück zum Zitat Saccheri MC, Cianciulli TF, Lax JA, Gagliardi JA, Cáceres GL, Quarin AE, Kisinovsky I, Rozenfeld PA, Reisin RC, AADELFA (2013) Two-dimensional speckle tracking echocardiography for early detection of myocardial damage in young patients with Fabry disease. Echocardiography 30:1069–1077PubMed Saccheri MC, Cianciulli TF, Lax JA, Gagliardi JA, Cáceres GL, Quarin AE, Kisinovsky I, Rozenfeld PA, Reisin RC, AADELFA (2013) Two-dimensional speckle tracking echocardiography for early detection of myocardial damage in young patients with Fabry disease. Echocardiography 30:1069–1077PubMed
12.
Zurück zum Zitat Spinelli L, Imbriaco M, Nappi C, Nicolai E, Giugliano G, Ponsiglione A, Diomiaiuti TC, Riccio E, Duro G, Pisani A, Trimarco B, Cuocolo A (2018) Early cardiac involvement affects left ventricular longitudinal function in females carrying α-galactosidase A mutation: role of hybrid positron emission tomography and magnetic resonance imaging and speckle tracking echocardiography. Circ Cardiovasc Imaging. https://doi.org/10.1161/CIRCIMAGING.117.007019 CrossRefPubMed Spinelli L, Imbriaco M, Nappi C, Nicolai E, Giugliano G, Ponsiglione A, Diomiaiuti TC, Riccio E, Duro G, Pisani A, Trimarco B, Cuocolo A (2018) Early cardiac involvement affects left ventricular longitudinal function in females carrying α-galactosidase A mutation: role of hybrid positron emission tomography and magnetic resonance imaging and speckle tracking echocardiography. Circ Cardiovasc Imaging. https://​doi.​org/​10.​1161/​CIRCIMAGING.​117.​007019 CrossRefPubMed
13.
Zurück zum Zitat Labombarda F, Saloux E, Milesi G, Bienvenu B (2017) Loss of base-to-apex circumferential strain gradient: a specific pattern of Fabry&nbsp;cardiomyopathy? Echocardiography 34:504–510PubMed Labombarda F, Saloux E, Milesi G, Bienvenu B (2017) Loss of base-to-apex circumferential strain gradient: a specific pattern of Fabry&nbsp;cardiomyopathy? Echocardiography 34:504–510PubMed
14.
Zurück zum Zitat Morris DA, Blaschke D, Canaan-Kühl S, Krebs A, Knobloch G, Walter TC, Haverkamp W (2015) Global cardiac alterations detected by speckle-tracking echocardiography in Fabry disease: left ventricular, right ventricular, and left atrial dysfunction are common and linked to worse symptomatic status. Int J Cardiovasc Imaging 31:301–313PubMed Morris DA, Blaschke D, Canaan-Kühl S, Krebs A, Knobloch G, Walter TC, Haverkamp W (2015) Global cardiac alterations detected by speckle-tracking echocardiography in Fabry disease: left ventricular, right ventricular, and left atrial dysfunction are common and linked to worse symptomatic status. Int J Cardiovasc Imaging 31:301–313PubMed
15.
Zurück zum Zitat Kidney Disease: Improving Global Outcomes (KDIGO) and CKD Work Group (2013) KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 3:1–150 Kidney Disease: Improving Global Outcomes (KDIGO) and CKD Work Group (2013) KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 3:1–150
16.
Zurück zum Zitat Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233–270PubMed Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233–270PubMed
17.
Zurück zum Zitat de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251–1260PubMed de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251–1260PubMed
18.
Zurück zum Zitat Spinelli L, Pellegrino T, Pisani A, Giudice CA, Riccio E, Imbriaco M, Trimarco B, Cuocolo A (2016) Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by (123) I-meta-iodobenzylguanidine imaging in Anderson–Fabry disease. Eur J Nucl Med Mol Imaging 43:729–739PubMed Spinelli L, Pellegrino T, Pisani A, Giudice CA, Riccio E, Imbriaco M, Trimarco B, Cuocolo A (2016) Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by (123) I-meta-iodobenzylguanidine imaging in Anderson–Fabry disease. Eur J Nucl Med Mol Imaging 43:729–739PubMed
19.
Zurück zum Zitat Nordin S, Kozor R, Bulluck H, Castelletti S, Rosmini S, Abdel-Gadir A, Baig S, Mehta A, Hughes D, Moon JC (2016) Cardiac Fabry disease with late gadolinium enhancement is a chronic inflammatory cardiomyopathy. J Am Coll Cardiol 68:1705–1711 Nordin S, Kozor R, Bulluck H, Castelletti S, Rosmini S, Abdel-Gadir A, Baig S, Mehta A, Hughes D, Moon JC (2016) Cardiac Fabry disease with late gadolinium enhancement is a chronic inflammatory cardiomyopathy. J Am Coll Cardiol 68:1705–1711
20.
Zurück zum Zitat Torralba-Cabeza MA, Olivera S, Hughes DA, Pastores GM, Mateo RN, Perez-Calvo J (2011) Cystatin C and NT-proBNP as prognostic biomarkers in Fabry disease. Mol Genet Metab 104:301–307PubMed Torralba-Cabeza MA, Olivera S, Hughes DA, Pastores GM, Mateo RN, Perez-Calvo J (2011) Cystatin C and NT-proBNP as prognostic biomarkers in Fabry disease. Mol Genet Metab 104:301–307PubMed
21.
Zurück zum Zitat Coats CJ, Parisi V, Ramos M, Janagarajan K, O’Mahony C, Dawnay A, Lachmann RH, Murphy E, Mehta A, Hughes D, Elliott PM (2013) N-terminal pro-brain natriuretic peptide measurement in diagnosis of cardiac involvement of anderson-fabry disease. Am J Cardiol 111:111–117PubMed Coats CJ, Parisi V, Ramos M, Janagarajan K, O’Mahony C, Dawnay A, Lachmann RH, Murphy E, Mehta A, Hughes D, Elliott PM (2013) N-terminal pro-brain natriuretic peptide measurement in diagnosis of cardiac involvement of anderson-fabry disease. Am J Cardiol 111:111–117PubMed
22.
Zurück zum Zitat Vijapurapu R, Nordin S, Shanat Baig S, Liu B, Rosmini S, Augusto J, Tchan M, Hughes DA, Geberhiwot T, Moon JC, Steeds RP, Kozor R (2019) Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease. Heart 105:470–476PubMed Vijapurapu R, Nordin S, Shanat Baig S, Liu B, Rosmini S, Augusto J, Tchan M, Hughes DA, Geberhiwot T, Moon JC, Steeds RP, Kozor R (2019) Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease. Heart 105:470–476PubMed
23.
Zurück zum Zitat Santambrogio GM, Maloberti A, Vallerio P, Peritore A, Spanò F, Occhi L, Musca F, Belli O, De Chiara B, Casadei F, Facchetti R, Turazza F, Manfredini E, Giannattasio C, Moreo A (2019) Could two-dimensional radial strain be considered as a novel tool to identify pre-clinical hypertrophic cardiomyopathy mutation carriers? Int J Cardiovasc Imaging 35:2167–2175PubMed Santambrogio GM, Maloberti A, Vallerio P, Peritore A, Spanò F, Occhi L, Musca F, Belli O, De Chiara B, Casadei F, Facchetti R, Turazza F, Manfredini E, Giannattasio C, Moreo A (2019) Could two-dimensional radial strain be considered as a novel tool to identify pre-clinical hypertrophic cardiomyopathy mutation carriers? Int J Cardiovasc Imaging 35:2167–2175PubMed
24.
Zurück zum Zitat Weidemann F, Breunig F, Beer M, Sandstede J, Turschner O, Voelker W, Ertl G, Knoll A, Wanner C, Strotmann JM (2003) Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation 108:1299–1301PubMed Weidemann F, Breunig F, Beer M, Sandstede J, Turschner O, Voelker W, Ertl G, Knoll A, Wanner C, Strotmann JM (2003) Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation 108:1299–1301PubMed
25.
Zurück zum Zitat Mizuguchi Y, Oishi Y, Miyoshi H, Iuchi A, Nagase N, Oki T (2008) The functional role of longitudinal, circumferential, and radial myocardial deformation for regulating the early impairment of left ventricular contraction and relaxation in patients with cardiovascular risk factors: a study with two-dimensional strain imaging. J Am Soc Echocardiogr 21:1138–1144PubMed Mizuguchi Y, Oishi Y, Miyoshi H, Iuchi A, Nagase N, Oki T (2008) The functional role of longitudinal, circumferential, and radial myocardial deformation for regulating the early impairment of left ventricular contraction and relaxation in patients with cardiovascular risk factors: a study with two-dimensional strain imaging. J Am Soc Echocardiogr 21:1138–1144PubMed
26.
Zurück zum Zitat Wang J, Khoury DS, Yue Y, Torre-Amione G, Nagueh SF (2008) Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure. Eur Heart J 29:1283–1289PubMed Wang J, Khoury DS, Yue Y, Torre-Amione G, Nagueh SF (2008) Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure. Eur Heart J 29:1283–1289PubMed
27.
Zurück zum Zitat Nishimura K, Okayama H, Inoue K, Saito M, Yoshii T, Hiasa G, Sumimoto T, Inaba S, Ogimoto A, Funada J, Higaki J (2012) Direct measurement of radial strain in the inner-half layer of the left ventricular wall in hypertensive patients. J Cardiol 59:64–71PubMed Nishimura K, Okayama H, Inoue K, Saito M, Yoshii T, Hiasa G, Sumimoto T, Inaba S, Ogimoto A, Funada J, Higaki J (2012) Direct measurement of radial strain in the inner-half layer of the left ventricular wall in hypertensive patients. J Cardiol 59:64–71PubMed
28.
Zurück zum Zitat van den Dorpel MMP, Heinonen I, Snelder SM, Vos HJ, Sorop O, van Domburg RT, Merkus D, Duncker DJ, van Dalen BM (2018) Early detection of left ventricular diastolic dysfunction using conventional and speckle tracking echocardiography in a large animal model of metabolic dysfunction. Int J Cardiovasc Imaging 34:743–749PubMed van den Dorpel MMP, Heinonen I, Snelder SM, Vos HJ, Sorop O, van Domburg RT, Merkus D, Duncker DJ, van Dalen BM (2018) Early detection of left ventricular diastolic dysfunction using conventional and speckle tracking echocardiography in a large animal model of metabolic dysfunction. Int J Cardiovasc Imaging 34:743–749PubMed
29.
Zurück zum Zitat Lancellotti P, Donal E, Magne J, O’Connor K, Moonen ML, Cosyns B, Pierard LA (2010) Impact of global left ventricular afterload on left ventricular function in asymptomatic severe aortic stenosis: a two-dimensional speckle-tracking study. Euro J Echocardiogr 11:537–543 Lancellotti P, Donal E, Magne J, O’Connor K, Moonen ML, Cosyns B, Pierard LA (2010) Impact of global left ventricular afterload on left ventricular function in asymptomatic severe aortic stenosis: a two-dimensional speckle-tracking study. Euro J Echocardiogr 11:537–543
30.
Zurück zum Zitat Urbano-Moral JA, Rowin EJ, Maron MS, Crean A, Pandian NG (2014) Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 7:11–19PubMed Urbano-Moral JA, Rowin EJ, Maron MS, Crean A, Pandian NG (2014) Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 7:11–19PubMed
31.
Zurück zum Zitat Spinelli L, Nicolai E, Acampa W, Imbriaco M, Pisani A, Rao MA, Scopacasa F, Cianciaruso B, De Luca N, Cuocolo A (2008) Cardiac performance during exercise in patients with Fabry’s disease. Eur J Clin Invest 38:910–917PubMed Spinelli L, Nicolai E, Acampa W, Imbriaco M, Pisani A, Rao MA, Scopacasa F, Cianciaruso B, De Luca N, Cuocolo A (2008) Cardiac performance during exercise in patients with Fabry’s disease. Eur J Clin Invest 38:910–917PubMed
32.
Zurück zum Zitat Aerts JM, Groener JE, Kuiper S, Donker-Koopman WE, Strijland A, Ottenhoff R, van Roomen C, Mirzaian M, Wijburg FA, Linthorst GE, Vedder AC, Rombach SM, Cox-Brinkman J, Somerharju P, Boot RG, Hollak CE, Brady RO, Poorthuis BJ (2008) Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci USA 105:2812–2817PubMedPubMedCentral Aerts JM, Groener JE, Kuiper S, Donker-Koopman WE, Strijland A, Ottenhoff R, van Roomen C, Mirzaian M, Wijburg FA, Linthorst GE, Vedder AC, Rombach SM, Cox-Brinkman J, Somerharju P, Boot RG, Hollak CE, Brady RO, Poorthuis BJ (2008) Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci USA 105:2812–2817PubMedPubMedCentral
33.
Zurück zum Zitat Brakch N, Dormond O, Bekri S, Golshayan D, Correvon M, Mazzolai L, Steinmann B, Barbey F (2010) Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease. Eur Heart J 31:67–76PubMed Brakch N, Dormond O, Bekri S, Golshayan D, Correvon M, Mazzolai L, Steinmann B, Barbey F (2010) Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease. Eur Heart J 31:67–76PubMed
34.
Zurück zum Zitat Barbey F, Brakch N, Linhart A, Rosenblatt-Velin N, Jeanrenaud X, Qanadli S, Steinmann B, Burnier M, Palecek T, Bultas J, Hayoz D (2006) Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition. Arterioscler Thromb Vasc Biol 26:839–844PubMed Barbey F, Brakch N, Linhart A, Rosenblatt-Velin N, Jeanrenaud X, Qanadli S, Steinmann B, Burnier M, Palecek T, Bultas J, Hayoz D (2006) Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition. Arterioscler Thromb Vasc Biol 26:839–844PubMed
35.
Zurück zum Zitat Heare T, Alp NJ, Priestman DA, Kulkarni AB, Qasba P, Butters TD, Dwek RA, Clarke K, Channon KM, Platt FM (2007) Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease: partial prevention by N-butyldeoxynojirimycin treatment. J Inherit Metab Dis 30:79–87PubMed Heare T, Alp NJ, Priestman DA, Kulkarni AB, Qasba P, Butters TD, Dwek RA, Clarke K, Channon KM, Platt FM (2007) Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease: partial prevention by N-butyldeoxynojirimycin treatment. J Inherit Metab Dis 30:79–87PubMed
36.
Zurück zum Zitat Park S, Kim JA, Joo KY, Choi S, Choi EN, Shin JA, Han KH, Jung SC, Suh SH (2011) Globotriaosylceramide leads to K(Ca)3.1 channel dysfunction: a new insight into endothelial dysfunction in Fabry disease. Cardiovasc Res 89:290–299PubMed Park S, Kim JA, Joo KY, Choi S, Choi EN, Shin JA, Han KH, Jung SC, Suh SH (2011) Globotriaosylceramide leads to K(Ca)3.1 channel dysfunction: a new insight into endothelial dysfunction in Fabry disease. Cardiovasc Res 89:290–299PubMed
37.
Zurück zum Zitat Shen JS, Meng XL, Moore DF, Quirk JM, Shayman JA, Schiffmann R, Kaneski CR (2008) Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells. Mol Genet Metab 95:163–168PubMedPubMedCentral Shen JS, Meng XL, Moore DF, Quirk JM, Shayman JA, Schiffmann R, Kaneski CR (2008) Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells. Mol Genet Metab 95:163–168PubMedPubMedCentral
38.
Zurück zum Zitat Lucke T, Hoppner W, Schmidt E, Illsinger S, Das AM (2004) Fabry disease: reduced activities of respiratory chain enzymes with decreased levels of energy-rich phosphates in fibroblasts. Mol Genet Metab 82:93–97PubMed Lucke T, Hoppner W, Schmidt E, Illsinger S, Das AM (2004) Fabry disease: reduced activities of respiratory chain enzymes with decreased levels of energy-rich phosphates in fibroblasts. Mol Genet Metab 82:93–97PubMed
39.
Zurück zum Zitat Machann W, Breunig F, Weidemann F, Sandstede J, Hahn D, Köstler H, Neubauer S, Wanner C, Beer M (2011) Cardiac energy metabolism is disturbed in Fabry disease and improves with enzyme replacement therapy using recombinant human galactosidase A. Eur J Heart Fail 13:278–283PubMed Machann W, Breunig F, Weidemann F, Sandstede J, Hahn D, Köstler H, Neubauer S, Wanner C, Beer M (2011) Cardiac energy metabolism is disturbed in Fabry disease and improves with enzyme replacement therapy using recombinant human galactosidase A. Eur J Heart Fail 13:278–283PubMed
40.
Zurück zum Zitat Nappi C, Altiero M, Imbriaco M, Nicolai E, Giudice CA, Aiello M, Diomiaiuti CT, Pisani A, Spinelli L, Cuocolo A (2015) First experience of simultaneous PET/MRI for the early detection of cardiac involvement in patients with Anderson–Fabry disease. Eur J Nucl Med Mol Imaging 42:1025–1031PubMed Nappi C, Altiero M, Imbriaco M, Nicolai E, Giudice CA, Aiello M, Diomiaiuti CT, Pisani A, Spinelli L, Cuocolo A (2015) First experience of simultaneous PET/MRI for the early detection of cardiac involvement in patients with Anderson–Fabry disease. Eur J Nucl Med Mol Imaging 42:1025–1031PubMed
41.
Zurück zum Zitat Hayashi Y, Hanawa H, Jiao S, Hasegawa G, Ohno Y, Yoshida K, Suzuki T, Kashimura T, Obata H, Tanaka K, Watanabe T, Minamino T (2015) Elevated endomyocardial biopsy macrophage-related markers in intractable myocardial diseases. Inflammation 38:2288–2299PubMed Hayashi Y, Hanawa H, Jiao S, Hasegawa G, Ohno Y, Yoshida K, Suzuki T, Kashimura T, Obata H, Tanaka K, Watanabe T, Minamino T (2015) Elevated endomyocardial biopsy macrophage-related markers in intractable myocardial diseases. Inflammation 38:2288–2299PubMed
42.
Zurück zum Zitat Chen KH, Chien Y, Wang KL, Leu HB, Hsiao CY, Lai YH, Wang CY, Chang YL, Lin SJ, Niu DM, Chiou SH, Yu WC (2016) Evaluation of proinflammatory prognostic biomarkers for Fabry cardiomyopathy with enzyme replacement therapy. Can J Cardiol 32:1221.e1-1221.e9 Chen KH, Chien Y, Wang KL, Leu HB, Hsiao CY, Lai YH, Wang CY, Chang YL, Lin SJ, Niu DM, Chiou SH, Yu WC (2016) Evaluation of proinflammatory prognostic biomarkers for Fabry cardiomyopathy with enzyme replacement therapy. Can J Cardiol 32:1221.e1-1221.e9
43.
Zurück zum Zitat Amzulescu MS, De Craene M, Langet H, Pasquet A, Vancraeynest D, Pouleur AC, Vanoverschelde JL, Gerber BL (2019) Myocardial strain imaging: review of general principles, validation, and sources of discrepancies. Eur Heart J Cardiovasc Imaging 20:605–619PubMedPubMedCentral Amzulescu MS, De Craene M, Langet H, Pasquet A, Vancraeynest D, Pouleur AC, Vanoverschelde JL, Gerber BL (2019) Myocardial strain imaging: review of general principles, validation, and sources of discrepancies. Eur Heart J Cardiovasc Imaging 20:605–619PubMedPubMedCentral
44.
Zurück zum Zitat Teraguchi H, Tekenaka T, Yoshida A, Taguchi S, Ninomiya K, Yoshida H, Horinouchi M, Yonezawa S, Nakao S, Minagoe S, Tei S (2004) End-stage cardiac manifestations and autopsy findings in patients with cardiac Fabry disease. J Cardiol 43:98–99PubMed Teraguchi H, Tekenaka T, Yoshida A, Taguchi S, Ninomiya K, Yoshida H, Horinouchi M, Yonezawa S, Nakao S, Minagoe S, Tei S (2004) End-stage cardiac manifestations and autopsy findings in patients with cardiac Fabry disease. J Cardiol 43:98–99PubMed
45.
Zurück zum Zitat Kawano M, Takenaka T, Otsuji Y, Teraguchi H, Yoshifuku S, Yuasa T, Yu B, Miyata M, Hamasaki S, Minagoe S, Kanmura Y, Tei C (2007) Significance of asymmetric basal posterior wall thinning in patients with cardiac Fabry’s disease. Am J Cardiol 99:261–263PubMed Kawano M, Takenaka T, Otsuji Y, Teraguchi H, Yoshifuku S, Yuasa T, Yu B, Miyata M, Hamasaki S, Minagoe S, Kanmura Y, Tei C (2007) Significance of asymmetric basal posterior wall thinning in patients with cardiac Fabry’s disease. Am J Cardiol 99:261–263PubMed
46.
Zurück zum Zitat Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G, Fontana M, Maestrini V, Flett AS, Robson MD, Lachmann RH, Murphy E, Mehta A, Hughes D, Neubauer S, Elliott PM, Moon JC (2013) Identification and assessment of Anderson–Fabry disease by cardiovascular magnetic resonance non-contrast myocardial T1 mapping. Circ Cardiovasc Imaging 6:392–398PubMed Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G, Fontana M, Maestrini V, Flett AS, Robson MD, Lachmann RH, Murphy E, Mehta A, Hughes D, Neubauer S, Elliott PM, Moon JC (2013) Identification and assessment of Anderson–Fabry disease by cardiovascular magnetic resonance non-contrast myocardial T1 mapping. Circ Cardiovasc Imaging 6:392–398PubMed
Metadaten
Titel
Left ventricular radial strain impairment precedes hypertrophy in Anderson–Fabry disease
verfasst von
Letizia Spinelli
Giuseppe Giugliano
Massimo Imbriaco
Giovanni Esposito
Carmela Nappi
Eleonora Riccio
Andrea Ponsiglione
Antonio Pisani
Alberto Cuocolo
Bruno Trimarco
Publikationsdatum
18.04.2020
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 8/2020
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-020-01847-z

Weitere Artikel der Ausgabe 8/2020

The International Journal of Cardiovascular Imaging 8/2020 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.